Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Statins: panacea for sepsis?

Marius Terblanche1, Yaniv Almog, Robert S Rosenson

  • 1Interdepartmental Division of Critical Care Medicine, Sunnybrook and Women's College Health Science Centre, Toronto, Canada. marius.terblanche@icunet.org

The Lancet. Infectious Diseases
|March 24, 2006
PubMed
Summary

Statins may offer a new way to treat and prevent sepsis, a dangerous systemic immune response to infection. Further clinical trials are needed to confirm their safety and effectiveness in critically ill patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Association between ABO Blood Groups, Carotid Stenosis and Atherosclerotic Plaque Burden: A Retrospective Cohort Study.

The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques·2026
Same author

Regression of carotid atherosclerosis in high-risk individuals with proprotein convertase subtilisin/kexin type 9 inhibitors.

Lipids·2025
Same author

The Long-Term Efficacy and Safety of Evinacumab in Patients With Homozygous Familial Hypercholesterolemia.

JACC. Advances·2024
Same author

Heparin Dose Intensity and Organ Support-Free Days in Patients Hospitalized for COVID-19.

JACC. Advances·2024
Same author

Lipoprotein(a) and the Risk for Recurrent Ischemic Stroke Events.

JACC. Advances·2024
Same author

Hypertriglyceridemia and Multiorgan Disease Among U.S. Adults.

JACC. Advances·2024

Area of Science:

  • Immunology
  • Pharmacology
  • Critical Care Medicine

Background:

  • Sepsis is a life-threatening systemic immune response to localized infection, leading to organ dysfunction.
  • Statins are known for their vascular anti-inflammatory and injury-protective effects.
  • Preclinical data suggest statins may reduce sepsis-related morbidity and mortality.

Purpose of the Study:

  • To explore the potential of statins as a novel therapeutic and prophylactic agent for sepsis.
  • To review existing evidence on statins' role in sepsis management and prevention.
  • To highlight the need for randomized controlled trials in human sepsis patients.

Main Methods:

  • Review of animal studies demonstrating statin efficacy in sepsis models.
  • Analysis of limited human data on statin use in bacteremic and infected patients.

Related Experiment Videos

  • Discussion of statins' pleiotropic immunomodulatory and anti-inflammatory mechanisms.

    • Main Results:

    • Animal studies indicate statin administration prior to sepsis induction improves survival and reduces illness.
    • Human data suggest reduced mortality in bacteremic patients and lower sepsis risk in statin users.
    • Statins possess pleiotropic effects, including anti-inflammatory and immunomodulatory actions, supporting their potential in sepsis.

    Conclusions:

    • Statins show promise as a potential new treatment and prevention strategy for sepsis.
    • Further investigation through randomized controlled clinical trials is warranted.
    • Clinical trials should evaluate statin safety and efficacy in critically ill septic patients and high-risk settings.